Latest news
Construction of Delta Pharma’s $100m plant begins in Mirsarai, production expected by 2029 - The Business StandardThe Business Standard · Sun, 09 Aug 2026 01:37:31 GMTSpyGlass Pharma 2Q 2026: Net loss $(19.9)M, EPS $(0.59) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:22:06 GMTAlteogen signs $365m Hybrozyme licensing deal with pharma company - Pharmaceutical TechnologyPharmaceutical Technology · Thu, 06 Aug 2026 17:23:32 GMTSpyGlass Pharma Insiders Enjoying US$1.1m Appreciation On US$2.16m Investment - simplywall.stsimplywall.st · Wed, 05 Aug 2026 11:15:37 GMTNewAmsterdam Pharma Co N.V. Q2 2026: Revenue $3.7M, EPS $(0.52) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 11:11:01 GMTRoyalty Pharma: At The Right P/E, I'm In (But Not Here) (NASDAQ:RPRX) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 06:42:21 GMTNuvectis Pharma, Inc. 2Q 2026: Net loss $(7.02)M, EPS $(0.30) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 13:11:01 GMTSwiss pharma firm Sandoz to pay $450m in US antitrust suit - SWI swissinfo.chSWI swissinfo.ch · Mon, 03 Aug 2026 07:05:09 GMT